Breast: Page 223

Hologic makes $1B private offering
By AuntMinnie.com staff writers
Women's imaging vendor Hologic has launched a private offering to institutional investors of $1 billion senior notes, due in 2022.
June 17, 2015
Hologic's LaVance steps down as chairman
By AuntMinnie.com staff writers
David LaVance Jr. has resigned as chairman of the board at women's imaging vendor Hologic.
June 16, 2015
FDA issues adverse MQSA report for ND hospital
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration has posted an adverse event report for a North Dakota hospital's mammography performance.
June 10, 2015
Lumicell gets FDA nod for breast surgery imaging trial
By AuntMinnie.com staff writers
Image-guidance firm Lumicell has received an investigational device exemption from the U.S. Food and Drug Administration allowing it to launch a pilot study for intraoperative imaging of breast cancer during surgery.
June 4, 2015
Global breast imaging market to reach $4B by 2019
By AuntMinnie.com staff writers
The market for breast imaging technology is estimated to reach $4 billion by 2019, driven by the rising incidence of breast cancer around the world, according to a new report from Transparency Market Research.
June 3, 2015
ISCT livestream starts Sunday; mammo cuts cancer mortality 40%; ISMRM wrap-up
By Brian Casey
June 3, 2015
ACA ups colon, breast cancer screening in newly insured
By AuntMinnie.com staff writers
The Affordable Care Act (ACA) may be behind recent increases in colorectal and breast cancer screening among the lower socioeconomic groups that benefit from being insured by it and Medicare, a new study in Cancer reveals.
June 3, 2015
FDA posts guidance on MQSA regulation of DBT units
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has posted a frequently asked questions page on its website regarding digital breast tomosynthesis (DBT) and Mammography Quality Standards Act (MQSA) training requirements.
June 3, 2015
ISMRM 2015: DCE-MRI predicts response to breast chemo
By Wayne Forrest
TORONTO - A new method of dynamic contrast-enhanced (DCE) MRI is an "excellent early predictor" of treatment response and a good marker of residual cancer burden during and after neoadjuvant chemotherapy for breast cancer, according to a study at the International Society for Magnetic Resonance in Medicine (ISMRM) meeting.
June 3, 2015
2015 06 03 14 19 11 310 Dcemri Tudorica 200
NEJM: Breast cancer screening reduces mortality by 40%
By Kate Madden Yee
Another salvo in the screening mammography wars has been released in the form of a literature review in the New England Journal of Medicine suggesting that breast cancer screening reduces mortality by 40%. Both sides of the breast screening debate may be able to gain ammunition from the report's findings, however.
June 2, 2015
2015 06 02 14 33 55 47 Duffy Stephen 175
MBI is cost-effective adjunct for imaging dense breasts
By Kate Madden Yee
Adding molecular breast imaging (MBI) to screening mammography in women with dense breast tissue may increase overall costs and the rate of benign biopsies, but because the combination finds more cancer, the cost per cancer detected is lower than with mammography alone, according to a study published in the June issue of the American Journal of Roentgenology.
May 31, 2015
2015 05 29 11 30 43 229 Hruska Carrie 175
Densitas wins ISO certification
By AuntMinnie.com staff writers
Densitas has received certification from the International Organization for Standardization (ISO).
May 27, 2015
Previous Page
Page 223 of 579
Next Page